Skip to main content
Premium Trial:

Request an Annual Quote

Nucleic Acid Extraction System From Systaaq Diagnostic CE Marked

NEW YORK – Systaaq Diagnostic Products announced today that its automated nucleic acid extraction system, SuperExtract 32, and viral nucleic acid extraction kit for in vitro diagnostic use have been CE-IVD marked.

The product is now available for use by hospitals and health systems that recognize the designation.

The Manassas, Virginia-based company, which develops molecular diagnostic assays for the life science and diagnostics markets, said that SuperExtract 32 with the SuperExtract Viral Mag NA Purification kit provides high-quality purification of hepatitis and HIV viral nucleic acid from plasma and serum for viral detection and quantification. 

It added that its HBV and HCV tests recently also received CE marking, and the products will be launched soon in Europe, Asia, and South America.  

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.